Managers / Q2 2025 · view latest →
Valor Management LLC
CIK 0001846237 · 320 N. SANGAMON STREET, SUITE 1200, CHICAGO, IL, 60607 · (312) 683-1900
Summary
Valor Management LLC reported $238M in U.S.-listed holdings across 4 positions for Q2 2025.
The portfolio is heavily concentrated: HRMY alone accounts for 87.8% of reported value.
The book was largely unchanged from Q1 2025.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 88.4% · $210M
- ADR · 11.6% · $28M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| HRMYHARMONY BIOSCIENCES HLDGS IN | HELD | +0 | 6.62M | −$11M | $209M |
| BWAYBRAINSWAY LTD | HELD | +0 | 2.10M | +$8M | $28M |
| SONDQSONDER HOLDINGS INC | HELD | +0 | 476.3K | +$333,425 | $1M |
| BIOABIOAGE LABS INC | HELD | +0 | 13.1K | +$4,849 | $54,124 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | HRMYHARMONY BIOSCIENCES HLDGS INhistory → | COM | 87.82% | $209M | 6.62M |
| 2 | BWAYBRAINSWAY LTDhistory → | SPONSORED ADS | 11.62% | $28M | 2.10M |
| 3 | SONDQSONDER HOLDINGS INC | CLA | 0.54% | $1M | 476.3K |
| 4 | BIOABIOAGE LABS INC | COM | 0.02% | $54,124 | 13.1K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $181M | 5 | May 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $55M | 3 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $67M | 4 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $238M | 4 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $241M | 4 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $249M | 4 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $475M | 4 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $455M | 6 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $480M | 6 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $364M | 3 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $372M | 4 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $402M | 5 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $380M | 4 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $634M | 4 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $521M | 3 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $567M | 3 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | Under review | 4 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $628M | 4 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.